Pharmaceutical supply contracts

BARMER Beschaffung und Vergabe·Wuppertal, Germany·Deadline May 01, 2028 · 611 days left·Open·Supplies·Framework

Inscrivez-vous pour sauvegarder

Structured notice only

Titre original de l'avis

Germany – Pharmaceutical products – Arzneimittelverträge mit Beitrittsoption

35/100

Score d'opportunité

Needs reviewMedium complexity

SuppliesFrameworkOpen

Pourquoi ce score ?

Opportunité

35 / 100

Complexité

40 / 100

Facteurs de risque

Absence of estimated value or framework maximum makes it impossible to gauge potential revenue or pricing expectations.

The notice explicitly states it is not subject to EU procurement directives or German competition law (Kartellvergabere...

No procurement documents available

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

Description
Industries & Services
Capabilities
Market & Experience
Certifications

Aperçu

Moderate opportunity

Faits clés

Framework procurement
Supplies contract
3 lots
Duration until Jun 2028
Supply of pharmaceutical products for 5 specific active ingredients as defined in each lot.
Framework agreement with accession option, allowing additional parties to join the contract.

Afficher le résumé complet

This is a framework agreement with accession option (Rahmenvertrag mit Beitrittsoption) for pharmaceutical products issued by BARMER, a German statutory health insurance company. It covers 5 lots for specific active ingredients: Bimatoprost, Calcipotriol + Betamethasone dipropionate, Eltrombopag (excluding SAA), Eltrombopag (Revolade®), and Nintedanib. The contract is structured as a 2-year framework (2026-06-01 to 2028-06-30) with a possible 3-month extension. The notice is not a public procurement under EU law and is published voluntarily. Estimated value is not provided. The procedure is open, and submissions must be electronic via the buyer's portal. The tender is in German only. No award criteria or selection criteria are specified in the available data.

Risques

Absence of estimated value or framework maximum makes it impossible to gauge potential revenue or pricing expectations.

The notice explicitly states it is not subject to EU procurement directives or German competition law (Kartellvergabere...

No procurement documents available

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Administrative

Tenders must be submitted electronically via the buyer's portal at Ouvrir le portail
All documents must be in German; no other languages are accepted.
Maximum of 5 lots can be awarded and submitted.

Les exigences peuvent être incomplètes.

Acheteur

Nom

BARMER Beschaffung und Vergabe

Localisation

Wuppertal, Germany

Durée

May 2026 - Jun 2028

Catégorie

Pharmaceutical products

Détails de la procédure

Date de publication: 13 Apr 2026
Langues: German

Métadonnées de référence

Base juridique: 32014L0024

Identifiants de référence

ID de l'appel d'offres: 252831-2026

Documents (1)

Portail de soumission 1

Appels d'offres similaires

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3